Skip to main content
SpringerLink
Log in

Assessing Quality of Life in Older Adult Patients with Skin Disorders

  • Reference work entry
  • First Online:
Textbook of Aging Skin

  • 213 Accesses

Abstract

Older adults experience a number of skin diseases and age-related changes that substantially affect quality of life. This review of available literature briefly describes skin conditions associated with aging that affect the skin’s appearance (e.g., age spots, wrinkles, and prominent veins), function (e.g., decreases in skin barrier function, mechanical protection, sensory perception, wound-healing capability), and structure (e.g., dryness, roughness, and skin laxity). Summaries are provided for a number of quality of life instruments that can be used for adult dermatology patients to assess the effects of treatment and disease progression, perceptions of well-being, and the value that patients place on their dermatologic state of health. These include instruments assessing the effect of dermatology on overall health-related quality of life (e.g., Dermatology Life Quality Index, Family Dermatology Life Quality Index, and Skindex), an instrument assessing the impact on health-related quality of life of various consumer products (the Farage Quality of Life Questionnaire), and condition-specific measures (e.g., the Quality of Life Index for Atopic Dermatitis, Charing Cross Venous Ulcer Questionnaire, Pressure Ulcer Quality of Life, Psoriasis Disability Index, and Rosacea-Specific Quality of Life). Although a number of such validated dermatology-related instruments are available, an opportunity exists for developing and validating health-related quality of life measures specifically for older patients and the dermatologic conditions most pertinent to them.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,699.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. WHOQOL: measuring quality of life. World Health Organization CH-1211 Geneva 27. 1997. Switzerland.

    Google Scholar 

  2. Centers for Disease Control and Prevention. Health-Related Quality of Life (HRQOL). Centers for Disease Control and Prevention Atlanta, GA, USA. 2011.

    Google Scholar 

  3. Chwalow AJ. Cross-cultural validation of existing quality of life scales. Patient Educ Couns. 1995;26:313–8.

    Article  CAS  PubMed  Google Scholar 

  4. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273:59–65.

    Article  CAS  PubMed  Google Scholar 

  5. Johnson RJ, Wolinsky FD. The structure of health status among older adults: disease, disability, functional limitation, and perceived health. J Health Soc Behav. 1993;34:105–21.

    Article  CAS  PubMed  Google Scholar 

  6. Calman KC. Quality of life in cancer patients – an hypothesis. J Med Ethics. 1984;10:124–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Michalos AC. Multiple discrepancies theory (MDT). Soc Indic Res. 1985;16:347–413.

    Article  Google Scholar 

  8. Tsevat J, Weeks JC, Guadagnoli E, Tosteson AN, et al. Using health-related quality-of-life information: clinical encounters, clinical trials, and health policy. J Gen Intern Med. 1994;9:576–82.

    Article  CAS  PubMed  Google Scholar 

  9. Ware JJ, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.

    Article  PubMed  Google Scholar 

  10. Cella D, Yount S, Rothrock N, Gershon R, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007;45:S3–11.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Embretson SE, Reise SP. Item response theory for psychologists. Mahwah, NJ: Lawrence Erlbaum Associates; 2000.

    Google Scholar 

  12. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1–30.

    Article  CAS  PubMed  Google Scholar 

  13. McCombs K, Chen SC. Patient preference quality of life measures in dermatology. Dermatol Ther. 2007;20:102–9.

    Article  PubMed  Google Scholar 

  14. Khanna D, Ahmed M, Yontz D, Ginsburg SS, et al. Willingness to pay for a cure in patients with chronic gout. Med Decis Making. 2008;28:606–13.

    Article  PubMed  Google Scholar 

  15. Tengs TO, Yu M, Luistro E. Health-related quality of life after stroke a comprehensive review. Stroke. 2001;32:964–72.

    Article  CAS  PubMed  Google Scholar 

  16. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–43.

    Article  CAS  PubMed  Google Scholar 

  17. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–92.

    Article  PubMed  Google Scholar 

  18. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375–84.

    Article  CAS  PubMed  Google Scholar 

  19. Kaplan R, Anderson JP, Ganiats GG. The quality of Well-Being Scale: rationale for a single quality of life index. In: Walker SR, Rosser RM, editors. Quality of Life assessment: key issues in the 1990s. Dordrecht: Kluwer Academic Publishers; 1993. p. 65–94.

    Chapter  Google Scholar 

  20. Farage MA, Miller KW, Elsner P, Maibach HI. Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci. 2008;30:87–95.

    Article  CAS  PubMed  Google Scholar 

  21. Farage MA, Miller KW, Sherman SN, Tsevat J. Assessing quality of life in older adult patients with skin disorders. Glob J Health Sci. 2012;4:119–31.

    PubMed  PubMed Central  Google Scholar 

  22. Chang AL, Wong JW, Endo JO, Norman RA. Geriatric dermatology review: major changes in skin function in older patients and their contribution to common clinical challenges. J Am Med Dir Assoc. 2013;14:724–30.

    Article  PubMed  Google Scholar 

  23. Guinot C, Malvy DJ, Ambroisine L, Latreille J, et al. Relative contribution of intrinsic vs extrinsic factors to skin aging as determined by a validated skin age score. Arch Dermatol. 2002;138:1454–60.

    Article  PubMed  Google Scholar 

  24. The Merck Manual of Geriatrics. Section 15, Dermatologic and sensory organ disorders. Chapter 122, Aging and the skin. Age-related changes in skin structure and function; photoaging. 2015 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ., USA.

    Google Scholar 

  25. Farage MA, Miller KW, Elsner P, Maibach HI. Structural characteristics of the aging skin: a review. Cutan Ocul Toxicol. 2007;26:343–57.

    Article  PubMed  Google Scholar 

  26. Kligman AM, Koblenzer C. Demographics and psychological implications for the aging population. Dermatol Clin. 1997;15:549–53.

    Article  CAS  PubMed  Google Scholar 

  27. Farage MA, Miller KW, Berardesca E, Maibach HI. Incontinence in the aged: contact dermatitis and other cutaneous consequences. Contact Dermatitis. 2007;57:211–7.

    Article  PubMed  Google Scholar 

  28. National Cancer Institute. SEER Stat Fact Sheets: melanoma of the skin. Surveillance, Epidemiology, and End Results Program. 2014. NCI; Rockville, MD-USA. http://seer.cancer.gov/statfacts/html/melan.html

  29. Elasy TA, Gaddy G. Measuring subjective outcomes: rethinking reliability and validity. J Gen Intern Med. 1998;13:757–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Chen SC. Dermatology Quality of Life instruments: sorting out the quagmire. J Invest Dermatol. 2007;127:2695–6.

    Article  CAS  PubMed  Google Scholar 

  31. Both H, Essink-Bot ML, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol. 2007;127:2726–39.

    Article  CAS  PubMed  Google Scholar 

  32. Willis GB. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks: Sage Publications; 2005.

    Book  Google Scholar 

  33. Aday LA, Cornelius LJ. Designing and conducting health surveys: a comprehensive guide. 2nd ed. San Francisco: Jossey-Bass; 1996.

    Google Scholar 

  34. Littenberg B, Partilo S, Licata A, Kattan MW. Paper Standard Gamble: the reliability of a paper questionnaire to assess utility. Med Decis Making. 2003;23:480–8.

    Article  PubMed  Google Scholar 

  35. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334.

    Article  Google Scholar 

  36. Bland JM, Altman DG. Cronbach’s alpha. BMJ. 1997;314:572.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Basra MK, Salek MS, Camilleri L, Sturkey R, et al. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology. 2015;230:27–33.

    Article  CAS  PubMed  Google Scholar 

  38. Farage MA, Nusair TL, Hanseman D, Sherman SN, et al. The Farage Quality of Life measure for consumer products: development and initial implementation. Appl Res Qual Life. 2010;5:1–25.

    Article  Google Scholar 

  39. Farage MA, Rodenberg C, Chen J. Translation and Validation of the Farage Quality of Life (FQoL) instrument for consumer products into traditional Chinese. Glob J Health Sci. 2013;5:1–12.

    Google Scholar 

  40. Sadick NS. The impact of cosmetic interventions on quality of life. Dermatol Online J. 2008;14:2.

    PubMed  Google Scholar 

  41. Beresniak A, de Linares Y, Krueger GG, Talarico S, et al. Validation of a new international quality-of-life instrument specific to cosmetics and physical appearance: BeautyQoL questionnaire. Arch Dermatol. 2012;148:1275–82.

    Article  PubMed  Google Scholar 

  42. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.

    Article  CAS  PubMed  Google Scholar 

  43. Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales – a measure of the impact of skin diseases. Br J Dermatol. 1997;136:202–6.

    Article  CAS  PubMed  Google Scholar 

  44. Basra MK, Sue-Ho R, Finlay AY. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol. 2007;156:528–38.

    Article  CAS  PubMed  Google Scholar 

  45. Chren MM, Lasek RJ, Quinn LM, Mostow EN, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707–13.

    Article  CAS  PubMed  Google Scholar 

  46. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133:1433–40.

    Article  CAS  PubMed  Google Scholar 

  47. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5:105–10.

    Article  CAS  PubMed  Google Scholar 

  48. He Z, Lu C, Chren MM, Zhang Z, et al. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health Qual Life Outcomes. 2014;12:4.

    Article  Google Scholar 

  49. Evers AW, Duller P, van de Kerkhof PC, van der Valk PG, et al. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol. 2008;158:101–8.

    CAS  PubMed  Google Scholar 

  50. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37:41–50.

    Article  CAS  PubMed  Google Scholar 

  51. Reich A, Stander S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol. 2009;89:236–44.

    Article  PubMed  Google Scholar 

  52. Majeski CJ, Johnson JA, Davison SN, Lauzon CJ. Itch Severity Scale: a self-report instrument for the measurement of pruritus severity. Br J Dermatol. 2007;156:667–73.

    Article  CAS  PubMed  Google Scholar 

  53. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33:350–7.

    Article  CAS  PubMed  Google Scholar 

  54. Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, et al. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol. 2008;59:234–44.

    Article  PubMed  Google Scholar 

  55. Chen SC, Yeung J, Chren MM. Scalpdex: a quality-of-life instrument for scalp dermatitis. Arch Dermatol. 2002;138:803–7.

    PubMed  Google Scholar 

  56. Smith JJ, Guest MG, Greenhalgh RM, Davies AH. Measuring the quality of life in patients with venous ulcers. J Vasc Surg. 2000;31:642–9.

    Article  CAS  PubMed  Google Scholar 

  57. Brazier JE, Harper R, Jones NM, O’Cathain A, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Abetz L, Sutton M, Brady L, McNulty P, et al. The Diabetic Foot Ulcer Scale (DFS): a quality of life instrument for use in clinical trials. Pract Diabet Int. 2002;19:167–75.

    Article  Google Scholar 

  59. Bann CM, Fehnel SE, Gagnon DD. Development and validation of the Diabetic Foot Ulcer Scale-Short Form (DFS-SF). Pharmacoeconomics. 2003;21:1277–90.

    Article  PubMed  Google Scholar 

  60. Farage MA, Miller KW, Berardesca E, Maibach HI. Clinical implications of aging skin: cutaneous disorders in the elderly. Am J Clin Dermatol. 2009;10:73–86.

    Article  PubMed  Google Scholar 

  61. Gorecki C, Brown JM, Cano S, Lamping DL, et al. Development and validation of a new patient-reported outcome measure for patients with pressure ulcers: the PU-QOL instrument. Health Qual Life Outcomes. 2013;11:95.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Rutherford C, Nixon J, Brown JM, Lamping DL, et al. Using mixed methods to select optimal mode of administration for a patient-reported outcome instrument for people with pressure ulcers. BMC Med Res Methodol. 2014;14:22.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Wollina U. Rosacea and rhinophyma in the elderly. Clin Dermatol. 2011;29:61–8.

    Article  PubMed  Google Scholar 

  64. Powell FC. Clinical practice. Rosacea. N Engl J Med. 2005;352:793–803.

    Article  CAS  PubMed  Google Scholar 

  65. Nicholson K, Abramova L, Chren MM, Yeung J, et al. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol. 2007;57:213–21.

    Article  PubMed  Google Scholar 

  66. Seidler AM, Kini SP, DeLong LK, Veledar E, et al. Preference-based measures in dermatology: an overview of utilities and willingness to pay. Dermatol Clin. 2012;30:223–9. xiii.

    Article  CAS  PubMed  Google Scholar 

  67. Schmitt J, Meurer M, Klon M, Frick KD. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol. 2008;158:351–9.

    Article  CAS  PubMed  Google Scholar 

  68. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, et al. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol. 1999;141:1067–75.

    Article  CAS  PubMed  Google Scholar 

  69. Chen S, Shaheen A, Garber A. Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis. A pilot study. Arch Dermatol. 1998;134:1602–8.

    CAS  PubMed  Google Scholar 

  70. Zug KA, Littenberg B, Baughman RD, Kneeland T, et al. Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Arch Dermatol. 1995;131:561–8.

    Article  CAS  PubMed  Google Scholar 

  71. Schiffner R, Schiffner-Rohe J, Gerstenhauer M, Hofstadter F, et al. Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients? Br J Dermatol. 2003;148:1153–60.

    Article  CAS  PubMed  Google Scholar 

  72. Seidler AM, Bayoumi AM, Goldstein MK, Cruz PDJ, et al. Willingness to pay in dermatology: assessment of the burden of skin diseases. J Invest Dermatol. 2012;132:1785–90.

    Article  CAS  PubMed  Google Scholar 

  73. Radtke MA, Schafer I, Gajur A, Langenbruch A, et al. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161:134–9.

    Article  CAS  PubMed  Google Scholar 

  74. Beikert FC, Langenbruch AK, Radtke MA, Augustin M. Willingness to pay and quality of life in patients with rosacea. J Eur Acad Dermatol Venereol. 2013;27:734–8.

    Article  CAS  PubMed  Google Scholar 

  75. Beikert FC, Langenbruch AK, Radtke MA, Kornek T, et al. Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res. 2014;306:279–86.

    Article  CAS  PubMed  Google Scholar 

  76. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132:236–44.

    Article  CAS  PubMed  Google Scholar 

  77. Schiffner R, Brunnberg S, Hohenleutner U, Stolz W, et al. Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains. Br J Dermatol. 2002;146:440–7.

    Article  CAS  PubMed  Google Scholar 

  78. Chen SC, Bayoumi AM, Soon SL, Aftergut K, et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc. 2004;9:160–8.

    Article  PubMed  Google Scholar 

  79. Caron M, Perrier LL, Emery MP. In 2012, the Patient-Reported Outcomes and Quality of Life Instruments Database (PROQOLID) Celebrates a Major Feat: Its 10th Anniversary! Patient Reported Outcomes Newsletter. Spring Issue 2012; 47, pp.26–27.

    Google Scholar 

  80. Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30:231–6. xiii.

    Article  CAS  PubMed  Google Scholar 

  81. Martin AR, Lookingbill DP, Botek A, Light J, et al. Health-related quality of life among patients with facial acne – assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26:380–5.

    Article  CAS  PubMed  Google Scholar 

  82. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol. 1989;14:194–8.

    Article  CAS  PubMed  Google Scholar 

  83. Kingsley DH. The development and validation of a quality of life measure for the impact of androgen-dependent alopecia [dissertation]. Portsmouth: Portsmouth University; 1999.

    Google Scholar 

  84. Mendoza TR, Osei JS, Shi Q, Duvic M. Development of the alopecia areata symptom impact scale. J Investig Dermatol Symp Proc. 2013;16:S51–2.

    Article  PubMed  Google Scholar 

  85. Whalley D, McKenna SP, Dewar AL, Erdman RA, et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol. 2004;150:274–83.

    Article  CAS  PubMed  Google Scholar 

  86. Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol. 2004;140:1513–9.

    Article  PubMed  Google Scholar 

  87. Erturk IE, Arican O, Omurlu IK, Sut N. Effect of the pruritus on the quality of life: a preliminary study. Ann Dermatol. 2012;24:406–12.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Hyland ME, Lay A, Thomson B. Quality of life of leg ulcer patients: questionnaire and preliminary findings. J Wound Care. 1994;3:294–8.

    Google Scholar 

  89. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996;14:485–96.

    Article  CAS  PubMed  Google Scholar 

  90. McKenna SP, Doward LC, Whalley D, Tennant A, et al. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis. 2004;63:162–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Roborel de Climens A, Bachelez H, Bagot M et al. Development of a unique tool reflecting patient and physician perceptions of psoriasis severity and treatment efficacy. Presented at: 20th Congress of the European Academy of Dermatology and Venereology (EADV); October 20 2011; Lisbon, Portugal.

    Google Scholar 

  92. Fredriksson T, Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatologica. 1978;157:238–44.

    Article  CAS  PubMed  Google Scholar 

  93. Drake LA, Patrick DL, Fleckman P, Andr J, et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol. 1999;41:189–96.

    Article  CAS  PubMed  Google Scholar 

  94. Jolly M, Pickard AS, Block JA, Kumar RB, et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012;42:56–65.

    Article  PubMed  Google Scholar 

  95. Doward LC, McKenna SP, Whalley D, Tennant A, et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis. 2009;68:196–200.

    Article  CAS  PubMed  Google Scholar 

  96. Symmons DP, Coppock JS, Bacon PA, Bresnihan B, et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med. 1988;69:927–37.

    CAS  PubMed  Google Scholar 

  97. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol. 1992;10:541–7.

    CAS  PubMed  Google Scholar 

  98. Bombardier C, Gladman DD, Urowitz MB, Caron D, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630–40.

    Article  CAS  PubMed  Google Scholar 

  99. Lilly E, Lu PD, Borovicka JH, Victorson D, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69:e11–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Winton Hill Business Center, The Procter & Gamble Company, 6110 Center Hill Avenue, 45224, Cincinnati, OH, USA

    Miranda A. Farage

  2. SNS Research, Cincinnati, OH, USA

    Susan N. Sherman

  3. Division of General Internal Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine and Cincinnati VA Medical Center, 231 Albert Sabin Way, 45267-0535, Cincinnati, OH, USA

    Joel Tsevat

  4. Margoshes-Miller Consulting, LLC, Cincinnati, OH, USA

    Kenneth W. Miller

Authors
  1. Miranda A. Farage
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth W. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan N. Sherman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joel Tsevat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miranda A. Farage .

Editor information

Editors and Affiliations

  1. Winton Hill Business Center, The Procter & Gamble Company , Cincinnati, Ohio, USA

    Miranda A. Farage

  2. Margoshes-Miller Consulting, LLC, Cincinnati, Ohio, USA

    Kenneth W. Miller

  3. Department of Dermatology, University of California, San Francisco, California, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Farage, M.A., Miller, K.W., Sherman, S.N., Tsevat, J. (2017). Assessing Quality of Life in Older Adult Patients with Skin Disorders. In: Farage, M., Miller, K., Maibach, H. (eds) Textbook of Aging Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47398-6_73

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-47398-6_73

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-47397-9

  • Online ISBN: 978-3-662-47398-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation